Page last updated: 2024-08-17

tetrabenazine and Basal Ganglia Diseases

tetrabenazine has been researched along with Basal Ganglia Diseases in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19907 (70.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aravind, VK; Krishnaram, VD; Neethiarau, V; Srinivasan, KG1
Papapetropoulos, S; Singer, C1
Dichgans, J; Schumm, F; Zeller, E1
Frey, KA; Gilman, S; Jewett, DM; Junck, L; Kilbourn, MR; Koeppe, RA; Lee, LC; Little, R; Lohman, M; Martorello, S; Vander Borght, TM1
Carnrike, CL; Faulstich, ME; Williamson, DA1
Gilligan, BS; Munro, OR; Veale, JL; Wodak, J1
Chase, TN1
Chien, C; Cole, JO; Kazamatsuri, H2
Chien, CP; Cole, JO; Kazamatsuri, H1

Reviews

2 review(s) available for tetrabenazine and Basal Ganglia Diseases

ArticleYear
Blepharospasm and Meige syndrome: a review of diagnostic, aetiological and treatment approaches.
    Journal of psychosomatic research, 1985, Volume: 29, Issue:1

    Topics: Acetylcholine; Basal Ganglia; Basal Ganglia Diseases; Behavior Therapy; Biofeedback, Psychology; Blepharospasm; Brain Stem; Diagnosis, Differential; Dyskinesia, Drug-Induced; Eyelid Diseases; Facial Nerve; Humans; Life Change Events; Lithium; Lithium Carbonate; Meige Syndrome; Oculomotor Muscles; Psychoanalytic Theory; Tetrabenazine; Trihexyphenidyl

1985
Drug-induced extrapyramidal disorders.
    Research publications - Association for Research in Nervous and Mental Disease, 1972, Volume: 50

    Topics: Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug-Related Side Effects and Adverse Reactions; Extrapyramidal Tracts; Haloperidol; Humans; Methyltyrosines; Movement Disorders; Phenothiazines; Phenylacetates; Probenecid; Reserpine; Synaptic Transmission; Tetrabenazine; Tranquilizing Agents; Trihexyphenidyl

1972

Trials

4 trial(s) available for tetrabenazine and Basal Ganglia Diseases

ArticleYear
Tetrabenazine in the treatment of extrapyramidal dyskinesias.
    The Medical journal of Australia, 1972, Nov-04, Volume: 2, Issue:19

    Topics: Adolescent; Adult; Athetosis; Basal Ganglia Diseases; Chorea; Clinical Trials as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Placebos; Spasm; Tetrabenazine

1972
Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
    Archives of general psychiatry, 1972, Volume: 27, Issue:1

    Topics: Adult; Aged; Basal Ganglia Diseases; Brain Chemistry; Clinical Trials as Topic; Dopamine; Evaluation Studies as Topic; Female; Haloperidol; Humans; Male; Mental Disorders; Middle Aged; Movement Disorders; Phenothiazines; Piperazines; Placebos; Tetrabenazine; Tranquilizing Agents

1972
Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Archives of general psychiatry, 1972, Volume: 27, Issue:1

    Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Brain Chemistry; Clinical Trials as Topic; Dopamine; Evaluation Studies as Topic; Female; Humans; Male; Mental Disorders; Middle Aged; Mouth; Movement Disorders; Placebos; Tetrabenazine; Time Factors; Tranquilizing Agents

1972
Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    The American journal of psychiatry, 1973, Volume: 130, Issue:4

    Topics: Adult; Basal Ganglia Diseases; Clinical Trials as Topic; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Haloperidol; Humans; Length of Stay; Male; Mental Disorders; Middle Aged; Movement Disorders; Placebos; Recurrence; Remission, Spontaneous; Substance Withdrawal Syndrome; Tetrabenazine; Time Factors; Tranquilizing Agents

1973

Other Studies

4 other study(ies) available for tetrabenazine and Basal Ganglia Diseases

ArticleYear
Wilson's disease--a rare psychiatric presentation.
    Journal of the Indian Medical Association, 2009, Volume: 107, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Adult; Basal Ganglia Diseases; Diagnosis, Differential; Hepatolenticular Degeneration; Humans; Male; Muscarinic Antagonists; Tetrabenazine; Trihexyphenidyl

2009
Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD).
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:8

    Topics: Anti-Dyskinesia Agents; Antiparkinson Agents; Basal Ganglia Diseases; Female; Hepatolenticular Degeneration; Humans; Middle Aged; Tetrabenazine

2005
[Spontaneous oral dyskinesia. Successful treatment with tetrabenazine (author's transl)].
    Archiv fur Psychiatrie und Nervenkrankheiten, 1981, Volume: 230, Issue:4

    Topics: Aged; Basal Ganglia Diseases; Blepharospasm; Dose-Response Relationship, Drug; Female; Humans; Male; Masticatory Muscles; Movement Disorders; Receptors, Dopamine; Tetrabenazine

1981
Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
    Annals of neurology, 1996, Volume: 40, Issue:6

    Topics: Adult; Aged; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Biological Transport; Cerebellar Diseases; Corpus Striatum; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Olivopontocerebellar Atrophies; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

1996